Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 68,696 |
|
|||||
| News | - | ||||||
| Day High | 0.459899 | Low High |
|||||
| Day Low | 0.4311 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cadrenal Therapeutics Inc | CVKD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0101 | 2.30% | 0.4501 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.44 | 0.4311 | 0.459899 | 0.4545 | 0.44 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 136 | 68,696 | US$ 0.4375813 | US$ 30,060 | - | 0.36 - 3.14 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:33:32 | 66 | US$ 0.46 | USD |
Cadrenal Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.2M | 16.01M | - | 0 | -8.36M | -0.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cadrenal Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVKD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.411 | 0.47 | 0.41 | 0.4401456 | 85,705 | 0.0391 | 9.51% |
| 1 Month | 0.6101 | 0.6199 | 0.36 | 0.4243238 | 492,575 | -0.16 | -26.23% |
| 3 Months | 1.32 | 1.3394 | 0.36 | 0.5855417 | 290,934 | -0.8699 | -65.90% |
| 6 Months | 0.453 | 2.17 | 0.36 | 0.8780068 | 276,917 | -0.0029 | -0.64% |
| 1 Year | 1.33 | 3.14 | 0.36 | 1.29 | 248,321 | -0.8799 | -66.16% |
| 3 Years | 5.71 | 6.75 | 0.36 | 1.66 | 242,386 | -5.26 | -92.12% |
| 5 Years | 5.71 | 6.75 | 0.36 | 1.66 | 242,386 | -5.26 | -92.12% |
Cadrenal Therapeutics Description
| Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib. |
